MG
MeiraGTx
MGTX·NASDAQNew York NYFounded 2015200 employees
Small CapbiotechPublicOphthalmologyGenetic Medicine
Platform: AAV Optogenetics
Market Cap
$0.4B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (MGTX)
Loading MGTX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Mavuzanubrutinib | MGT-3302 | Phase 1/2 | 1 | IL-17A | MCLCTCL | ||
| Gozezumab | MGT-3070 | Approved | 1 | TIGIT | PTSDCSU |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)